Brevican Core Protein
Introduction
Brevican core protein, also known as BCAN, is a prominent member of the lectican family of chondroitin sulfate proteoglycans (CSPGs), which are large macromolecules that form a crucial part of the extracellular matrix (ECM). While found in various tissues, brevican is particularly abundant in the central nervous system (CNS), where it plays a specialized role in the brain's structural and functional organization.
Biological Basis
The primary biological function of brevican in the CNS involves the regulation of neuronal plasticity and the stabilization of synaptic connections. It is a key component of the perineuronal net (PNN), a specialized ECM structure that envelops many neurons and synapses, particularly in the adult brain. Through its interactions with other ECM molecules like hyaluronan and tenascins, brevican helps to restrict excessive synaptic remodeling and maintain established neuronal circuits, thereby influencing learning, memory, and cognitive functions. Its chondroitin sulfate side chains are particularly important for these inhibitory roles.
Clinical Relevance
Alterations in brevican expression or function have been implicated in several neurological conditions. Following CNS injuries such as stroke or spinal cord injury, increased levels of brevican and other CSPGs contribute to the glial scar, which can inhibit axonal regeneration and functional recovery. Furthermore, brevican has been linked to neurodegenerative diseases like Alzheimer's disease, where ECM dysregulation is observed, and to neurological disorders such as epilepsy. In oncology, brevican is also under investigation for its role in certain brain tumors, including glioblastoma, where it may influence tumor cell migration and invasion.
Social Importance
Understanding the intricate roles of brevican is of significant social importance as it may lead to the development of new therapeutic strategies for a range of devastating neurological conditions. By targeting brevican or its associated pathways, researchers aim to overcome barriers to recovery after brain and spinal cord injuries, mitigate the progression of neurodegenerative diseases, and potentially improve treatments for aggressive brain cancers. Genetic variations affecting brevican could also offer insights into individual predispositions to these conditions and inform personalized medicine approaches, ultimately enhancing the quality of life for affected individuals and their families.
While research into the genetic underpinnings of traits such as brevican core protein provides valuable insights, it is important to acknowledge that the studies contributing to this understanding possess inherent limitations that influence the interpretation and generalizability of their findings.
Constraints in Genomic Coverage and Statistical Resolution
Many investigations utilized array-based genotyping platforms, such as the Affymetrix 100K SNP chip, which provided only partial coverage of the genome and specific gene regions. [1] This limited genomic coverage means that true genetic associations may have been missed if the causal variants were not directly assayed or sufficiently tagged by the available SNPs, thus potentially leading to false negative conclusions or an incomplete understanding of genetic influences. [2] Furthermore, the data from such arrays are often insufficient for a comprehensive study of a candidate gene, necessitating additional genotyping or imputation, which can introduce its own set of challenges. [1]
The statistical power of these studies was often constrained, particularly for detecting genetic effects that explain a small proportion of phenotypic variation, especially when stringent significance thresholds were applied to account for multiple testing. [3] This moderate sample size and associated power limitation contribute to challenges in replicating findings across different cohorts, as non-replication can stem from false positives in initial reports, variations in study design, or inadequate power to detect genuine, subtle effects. [4] Additionally, while imputation methods were employed to infer missing genotypes and broaden genomic coverage, these processes are not without error, with reported rates ranging from 1.46% to 2.14% per allele, which can affect the accuracy of downstream association analyses. [5]
Limitations in Generalizability and Population Specificity
A recurring limitation across the examined studies is the predominant focus on cohorts of European or Caucasian descent, often drawn from specific community-based samples or founder populations. [6] This demographic homogeneity inherently restricts the generalizability of the findings to other racial, ethnic, or ancestral groups, where genetic background, environmental exposures, and allele frequencies may differ significantly. [6] Although some studies implemented statistical adjustments like principal component analysis and genomic control to account for residual population stratification within the studied Caucasian populations, these methods do not address the fundamental lack of diversity, meaning identified associations might be population-specific rather than universal. [7]
Moreover, the age structure of several cohorts, which primarily included middle-aged to elderly individuals, introduces a potential for survival bias, as participants who survive to older ages may possess distinct genetic or lifestyle characteristics. [6] This age demographic further limits the applicability of the findings to younger populations, where the penetrance or manifestation of genetic effects could differ. [6] Consequently, while these studies provide valuable insights into the genetic underpinnings within their specific populations, caution is necessary when extrapolating the results to broader, more diverse human populations. [6]
Unexplored Environmental Interactions and Methodological Nuances
Many investigations did not comprehensively explore gene–environment interactions, which is a critical oversight given that genetic influences on phenotypes can be significantly modulated by environmental factors. [3] For instance, specific genetic associations with ACE and AGTR2 have been shown to vary depending on environmental exposures like dietary salt intake, suggesting that the absence of such analyses may lead to an incomplete understanding of the trait's etiology. [3] This omission means that potential environmental modifiers of genetic effects remain uncharacterized, potentially oversimplifying the complex interplay between genes and the environment in shaping phenotypic outcomes. [3]
Methodological choices also present specific nuances; for example, some analyses were performed only in a sex-pooled manner to manage the multiple testing burden, potentially overlooking sex-specific genetic associations that could exist exclusively in males or females. [1] Furthermore, the necessity for extensive statistical transformations to achieve approximate normality for certain protein distributions, while a robust analytical step, underscores the inherent variability and non-Gaussian nature of some phenotypic measurements. [8] While techniques like family-based association tests and adjustments for population stratification were employed, these cannot fully capture all unmeasured confounders or the intricate, context-dependent nature of genetic effects. [1]
Variants
Variants such as rs2365715, rs113184515, rs41267397, and rs11360 are found within or near the BCAN gene and its antisense RNA, BCAN-AS2. The BCAN gene encodes brevican, a crucial chondroitin sulfate proteoglycan that is a major component of the extracellular matrix in the central nervous system, playing vital roles in neural plasticity, cell migration, and maintaining the structural integrity of brain tissue. [6] BCAN-AS2 is an antisense RNA that may regulate BCAN gene expression, influencing the amount or activity of brevican protein. Alterations in these variants could potentially influence the expression or function of brevican, impacting its interactions with other matrix components and cells, which in turn affects processes like brain development, repair, and overall neurological function .
Other variants are associated with genes involved in metabolic regulation and lipid processing. The variant rs61738649 is located within or near MLXIPL, a gene encoding a transcription factor (MLXIPL) that plays a key role in regulating glucose and lipid metabolism, particularly in response to dietary carbohydrates. [9] This variant is associated with triglyceride levels, suggesting its influence on how the body processes fats. Similarly, rs13086758 is associated with THRB, which encodes Thyroid Hormone Receptor Beta, a nuclear receptor essential for mediating the effects of thyroid hormones on metabolism, growth, and development. [8] Dysregulation in these metabolic pathways could indirectly impact the extracellular matrix and proteins like brevican by altering cellular energy states or the availability of essential building blocks for tissue maintenance.
Variants linked to immune response and cellular adhesion also play a role. The variant rs56278466 is associated with MRC1, which encodes the Mannose Receptor C-Type 1, a receptor involved in innate immunity, endocytosis, and antigen presentation. [1] Another variant, rs7896624, is in a region encompassing MRC1 and SLC39A12, the latter of which encodes a zinc transporter crucial for maintaining cellular zinc homeostasis, a process important for immune function and enzymatic activity. The variant rs3757724 is associated with ITGB8, encoding Integrin Subunit Beta 8, a cell surface receptor involved in cell adhesion and signaling, particularly known for activating TGF-beta, a cytokine with broad roles in tissue repair and immune regulation. [6] Additionally, rs2071591 is linked to NFKBIL1 and ATP6V1G2; NFKBIL1 is implicated in the NF-kappaB pathway, a central regulator of inflammatory and immune responses, while ATP6V1G2 is involved in cellular acidification. These genes highlight the intricate connection between immune surveillance, cellular adhesion, and the integrity of the extracellular matrix, including brevican, which can be affected by inflammatory processes or altered cellular interactions.
Lastly, variants impacting fundamental processes like gene regulation and development contribute to the broader genetic landscape. The variant rs35107030 is associated with BCL7B, a component of the SWI/SNF chromatin remodeling complex, which is vital for controlling gene expression by altering chromatin structure and influencing cell growth and differentiation . Similarly, rs72733906 is linked to TCF12, a basic helix-loop-helix transcription factor that plays a significant role in various developmental processes, including neural and craniofacial development. Variations in these genes can broadly influence cellular identity, tissue formation, and the precise regulation of other genes, thereby potentially affecting the synthesis, modification, or turnover of extracellular matrix components like brevican, which is essential for proper tissue architecture and function. [6]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs2365715 rs113184515 |
BCAN-AS2, BCAN | protein measurement neuroimaging measurement blood protein amount brevican core protein measurement |
| rs56278466 | MRC1 | aspartate aminotransferase measurement liver fibrosis measurement ADGRE5/VCAM1 protein level ratio in blood CD200/CLEC4G protein level ratio in blood HYOU1/TGFBR3 protein level ratio in blood |
| rs3757724 | ITGB8 | brevican core protein measurement |
| rs61738649 | MLXIPL | brevican core protein measurement |
| rs41267397 rs11360 |
BCAN, BCAN-AS2 | brevican core protein measurement |
| rs35107030 | BCL7B | brevican core protein measurement level of oligodendrocyte-myelin glycoprotein in blood |
| rs13086758 | THRB | brevican core protein measurement level of neuronal pentraxin receptor in blood serum level of oligodendrocyte-myelin glycoprotein in blood |
| rs2071591 | NFKBIL1, ATP6V1G2 | late-onset myasthenia gravis brevican core protein measurement hemoglobin measurement Red cell distribution width |
| rs7896624 | MRC1 - SLC39A12 | brevican core protein measurement |
| rs72733906 | TCF12 | protein HEG homolog 1 measurement brevican core protein measurement level of soluble scavenger receptor cysteine-rich domain-containing protein SSC5D in blood |
References
[1] Yang, Qiong, et al. "Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007, p. S10.
[2] O'Donnell, Christopher J., et al. "Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007, p. S12.
[3] Vasan, Ramachandran S., et al. "Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007, p. S2.
[4] Sabatti, Chiara, et al. "Genome-wide association analysis of metabolic traits in a birth cohort from a founder population." Nature Genetics, vol. 41, no. 1, 2009, pp. 35-46.
[5] Willer, Cristen J., et al. "Newly identified loci that influence lipid concentrations and risk of coronary artery disease." Nature Genetics, vol. 40, no. 2, 2008, pp. 161-69.
[6] Benjamin, Emelia J., et al. "Genome-wide association with select biomarker traits in the Framingham Heart Study." BMC Medical Genetics, vol. 8, 2007, p. S11.
[7] Pare, Guillaume, et al. "Novel association of HK1 with glycated hemoglobin in a non-diabetic population: a genome-wide evaluation of 14,618 participants in the Women's Genome Health Study." PLoS Genetics, vol. 5, no. 1, 2009, e1000352.
[8] Melzer, David, et al. "A genome-wide association study identifies protein quantitative trait loci (pQTLs)." PLoS Genetics, vol. 4, no. 5, 2008, e1000072.
[9] Kathiresan, Sekar, et al. "Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans." Nature Genetics, vol. 40, no. 2, 2008, pp. 189-97.